Health Catalyst (HCAT) Misses Q4 Earnings and Revenue Estimates

Core Viewpoint - Health Catalyst (HCAT) reported quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of$ 0.11 per share, but showing an improvement from $0.02 per share a year ago [1][2] Financial Performance - The earnings surprise for the quarter was -63.64%, with a previous quarter's earnings of$ 0.07 per share also missing expectations of $0.10 per share, resulting in a -30% surprise [2] - Health Catalyst's revenues for the quarter ended December 2024 were$ 79.61 million, slightly missing the Zacks Consensus Estimate by 0.28%, compared to $75.08 million in the same quarter last year [3] - Over the last four quarters, the company has surpassed consensus revenue estimates two times [3] Stock Performance - Health Catalyst shares have declined approximately 30% since the beginning of the year, contrasting with the S&P 500's gain of 1.3% [4] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the market in the near future [7] Future Outlook - The current consensus EPS estimate for the upcoming quarter is$ 0.08 on revenues of $82.64 million, and for the current fiscal year, it is$ 0.38 on revenues of $338.89 million [8] - The estimate revisions trend for Health Catalyst is mixed, and changes in earnings expectations may occur following the recent earnings report [7] Industry Context - The Medical Info Systems industry, to which Health Catalyst belongs, is currently ranked in the bottom 49% of over 250 Zacks industries, suggesting potential challenges ahead [9] - The performance of Health Catalyst may be influenced by the overall outlook for the industry, as top-ranked industries tend to outperform lower-ranked ones significantly [9]